Niels Lund

Niels Lund is Vice President for Health Advocacy at Novo Nordisk, a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Niels is responsible for managing Changing Diabetes flagship programmes (including Cities Changing Diabetes), and the Access to Insulin Commitment (including Changing Diabetes in Children and Partnering for Change with the International Committee for the Red Cross). Furthermore, his responsibilities include partnerships with patient organisations and patient advocates globally. Niels acts as co-Chair of the Health and Healthcare Strategy Officers’ Council in the World Economic Forum (WEF) and is a contributor to WEF’s Agenda blog platform. Niels is MSc (Economics) from the University of Copenhagen and MBA (Health Services Management) from the George Washington University, Washington DC. He joined Novo Nordisk in 2007 as a health economist and worked in various functions before being appointed Vice President in 2012. Before joining Novo Nordisk, Niels worked in international development with assignments for UNICEF in India and the World Bank in Washington DC.